Evidence map›Paper›PMID 40109819›Full record

ArticleCureus2025

Navigating the Landscape of Direct-to-Consumer Telehealth Services.

Deesha D Desai, Ya-Han Crystal Zhang, Ambika Nohria, Vartan Pahalyants, Ata S Moshiri, Kristen I Lo Sicco

Abstract readEditorial
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Deesha D DesaiDepartment of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, USA.
Ya-Han Crystal ZhangThe Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, USA.
Ambika NohriaThe Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, USA.
Vartan PahalyantsThe Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, USA.
Ata S MoshiriThe Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, USA.
Kristen I Lo SiccoThe Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Direct-to-consumer (DTC) telehealth platforms have enhanced healthcare accessibility and convenience, particularly for Individuals in remote areas or those with mobility limitations. These platforms offer virtual medical consultations and prescription services, improving access to treatment for conditions such as hair loss, anxiety, depression, and sexual dysfunction. However, concerns regarding limited physician oversight, lack of transparency in provider qualifications, privacy risks, and potential financial and legal vulnerabilities highlight the need for stricter regulations. Addressing these issues is crucial to ensure patient protection and trust as the use of DTC telehealth services continues to grow.

Indexed as

alopeciadermatologydirect-to-consumerdtctelehealth

Identifiers

PMID40109819
PMCPMC11922300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.